Anti-human immunodeficiency virus type 1 activity of the nonnucleoside reverse transcriptase inhibitor GW678248 in combination with other antiretrovirals against clinical isolate viruses and in vitro selection for resistance.

Anti-human immunodeficiency virus type 1 activity of the nonnucleoside reverse transcriptase inhibitor GW678248 in combination with other antiretrovirals against clinical isolate viruses and in vitro selection for resistance.

Item
http://www.wikidata.org/entity/Q39609230
EASY-HIT: HIV full-replication technology for broad discovery of multiple classes of HIV inhibitorsMechanisms of inhibition of HIV replication by non-nucleoside reverse transcriptase inhibitors[Evaluation of antiretroviral therapy on mother to child transmission HIV in HIV-1 positive pregnant women: case of St. Camillus Medical Center in Ouagadougou, Burkina Faso].Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2005 - 2010).A robust, target-driven, cell-based assay for checkpoint kinase 1 inhibitors.Antiviral activity of GW678248, a novel benzophenone nonnucleoside reverse transcriptase inhibitorCharacterization of novel non-nucleoside reverse transcriptase (RT) inhibitor resistance mutations at residues 132 and 135 in the 51 kDa subunit of HIV-1 RT.The disposition and metabolism of GW695634: a non-nucleoside reverse transcriptase inhibitor (NNRTi) for treatment of HIV/AIDS.Virologic, immunologic, clinical, safety, and resistance outcomes from a long-term comparison of efavirenz-based versus nevirapine-based antiretroviral regimens as initial therapy in HIV-1-infected persons.Inhibition of HIV-1 or bacterial activation of macrophages by products of HIV-1-resistant human cells.Patterns of emergent resistance-associated mutations after initiation of non-nucleoside reverse-transcriptase inhibitor-containing antiretroviral regimens in Taiwan: a multicenter cohort study.
P2860

Anti-human immunodeficiency virus type 1 activity of the nonnucleoside reverse transcriptase inhibitor GW678248 in combination with other antiretrovirals against clinical isolate viruses and in vitro selection for resistance.

Item
http://www.wikidata.org/entity/Q39609230
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Anti-human immunodeficiency vi ...... itro selection for resistance.
@en
Anti-human immunodeficiency vi ...... itro selection for resistance.
@nl
type
label
Anti-human immunodeficiency vi ...... itro selection for resistance.
@en
Anti-human immunodeficiency vi ...... itro selection for resistance.
@nl
prefLabel
Anti-human immunodeficiency vi ...... itro selection for resistance.
@en
Anti-human immunodeficiency vi ...... itro selection for resistance.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Anti-human immunodeficiency vi ...... itro selection for resistance.
@en
P2093
P2860
P304
P31
P356
10.1128/AAC.49.11.4465-4473.2005
P407
P433
P478
P577
P698
P921
P932